What are the genetic causes and recommended testing for frontotemporal dementia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Genetics of Frontotemporal Dementia

The three most common genetic causes of frontotemporal dementia are C9orf72 repeat expansions (most common), GRN (progranulin) mutations, and MAPT (microtubule-associated protein tau) mutations, and you should screen for C9orf72 in all possible or probable bvFTD cases regardless of family history. 1

Primary Genetic Mutations

C9orf72 Repeat Expansion

  • Most common genetic cause accounting for 13.3% of FTD cases in recent cohorts 2
  • Presents with highly variable phenotypes including bvFTD, ALS, or combined presentations 1
  • Can manifest initially as psychiatric disorders (bipolar disorder, OCD, schizophrenia) that precede classic FTD symptoms by up to a decade 1
  • Severe psychotic symptoms (delusions, auditory hallucinations) occur in 21-56% of carriers—much more prominent than in sporadic FTD 1
  • Disease duration can extend up to 22 years with very slow progression in some cases 1
  • Critical pitfall: MRI and even FDG-PET can be completely normal at initial assessment 1

GRN (Progranulin) Mutations

  • Second most common, accounting for 6.7% of FTD cases 2
  • Visual hallucinations and delusions occur in up to 25% of patients and can be the presenting symptom 1
  • Strong association with late-onset bipolar disorder type 1 that evolves into bvFTD 1

MAPT Mutations

  • Third major genetic cause
  • Paranoid delusions and hallucinations described but less common than with C9orf72 or GRN 1

Recommended Genetic Testing Algorithm

Mandatory Testing Scenarios 1

  1. Test all three genes (C9orf72, GRN, MAPT) when:

    • Probable bvFTD with at least one first-degree relative with bvFTD, late-onset psychiatric disorder, ALS, or other early-onset neurodegenerative disease
    • Family history should be broadly defined to include Parkinson's disease, ALS, and unexplained late-onset psychiatric disorders—not just dementia
  2. Screen C9orf72 in ALL cases of:

    • Possible or probable bvFTD, regardless of family history 1
    • Late-onset psychiatric disorder with at least one first-degree relative with FTD or ALS 1
    • Suspected bvFTD not meeting full diagnostic criteria if prominent psychiatric symptoms or family history of late-onset psychiatric disorder present 1

Rationale for Broad C9orf72 Screening

The guidelines emphasize C9orf72 screening even without family history because 1:

  • Significant proportion of mutations occur in apparent sporadic cases
  • Strong overlap with psychiatric phenotypes makes clinical diagnosis challenging
  • Genetic testing serves as a diagnostic tool rather than just identifying etiology in clear cases
  • Can be justified even in absence of neuroimaging abnormalities

Genetic Contribution by Family History

  • Familial FTD: 48% carry pathogenic variants 2
  • Sporadic FTD: 11.4% carry pathogenic variants 2
  • Overall, genetic mutations account for 26.6% of all FTD-spectrum cases 2

Clinical Red Flags for Genetic FTD

C9orf72-Specific Features

  • Severe psychotic symptoms (persecutory, jealousy, grandiosity, religiosity, somatic delusions) 1
  • Prodromal psychiatric syndromes preceding behavioral changes by years 1
  • Family history of schizophrenia or autism spectrum disorder 1
  • Combined FTD-ALS presentation 1

GRN-Specific Features

  • Visual hallucinations as presenting symptom 1
  • Late-onset bipolar disorder evolving into dementia 1

Important Caveats

Severe psychotic symptoms are a potential marker of genetic abnormality: While psychotic symptoms occur in up to 26% of sporadic FTD, they are much less severe than in C9orf72 carriers and overshadowed by other behavioral changes 1

Pre-test counseling is essential: Patients and families should receive counseling on implications before testing, though access to specialized genetic counselors varies by country 1

Consider whole exome/genome sequencing: For families with multiple affected members (>2) when standard testing is negative 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.